Keyword Suggestion
Domain Informations
Oxbryta.com lookup results from whois.comlaude.com server:
- Domain created: 2017-12-15T17:57:11Z
- Domain updated: 2023-11-01T14:26:43Z
- Domain expires: 2028-12-15T17:57:11Z 2 Years, 339 Days left
- Website age: 8 Years, 25 Days
- Registrar Domain ID: 2200233422_DOMAIN_COM-VRSN
- Registrar Url: http://www.comlaude.com
- Registrar WHOIS Server: whois.comlaude.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +442074218250
- Name server:
- NS1.P201.DNS.ORACLECLOUD.NET
- NS2.P201.DNS.ORACLECLOUD.NET
- NS3.P201.DNS.ORACLECLOUD.NET
- NS4.P201.DNS.ORACLECLOUD.NET
Network
- inetnum : 104.16.0.0 - 104.31.255.255
- name : CLOUDFLARENET
- handle : NET-104-16-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2024-11-25
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse,Geofeed: https://api.cloudflare.com/local-ip-ranges.csv
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 104.18.40.222
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 104.18.40.222)
Spam Check (IP: 104.18.40.222)
Recent Searched Sites
› Katt.tunegenie.com (1 seconds ago) / US
› Huble.com (12 seconds ago) / CA
› Docs.distributed-ci.io (2 seconds ago) / US
› Flashtrucking.com (24 seconds ago) / US
› Boerlind.com (16 seconds ago) / US
› M.42zw.la (7 seconds ago) / HK
› 8ae.de (7 seconds ago) / DE
› Raai-school.ru (0 seconds ago) / RU
› Web.kyb-europe.com (6 seconds ago) / GB
› Docs.bvsalud.org (7 seconds ago) / BR
› Oxbryta.com (0 seconds ago) / US
› Wager247.us (1 seconds ago) / US
› Account.ybtour.co.kr (4 seconds ago) / KR
› Activeworld.s3.ap-southeast-2.amazonaws.com (0 seconds ago) / US
› Kookinglab.com (0 seconds ago) / UA
› Porkyexportt.com (0 seconds ago) / US
› Scrsheritage.com (12 seconds ago) / AU
› Importacionesracing824.com (7 seconds ago) / FR
› Merch4u.shop (2 seconds ago) / US
› Mycaoffer.com (8 seconds ago) / US
Websites Listing
We found Websites Listing below when search with oxbryta.com on Search Engine
The Official Patient Website for Oxbryta® (voxelotor) 500 ...
IMPORTANT SAFETY INFORMATION. Do not take OXBRYTA if you or your child have had an allergic reaction to voxelotor or any of the ingredients in OXBRYTA. See the end of the patient leaflet for a list of the ingredients in OXBRYTA. Before taking OXBRYTA, tell your healthcare provider about all of your medical conditions, including if you or your child:
Oxbryta.comAbout Oxbryta® (voxelotor) 500 mg Tablets and Oxbryta …
Oxbryta helps hemoglobin do its job by interfering with the very first step in the sickling process—polymerization. By impacting this very first step, Oxbryta may reduce sickling and hemolysis (the breakdown of red blood cells) that can lead to …
Oxbryta.comGBT’s Oxbryta® (voxelotor) Receives Positive CHMP …
2021-12-17 · About Oxbryta ® (voxelotor) Tablets Oxbryta (voxelotor) is an oral, once-daily therapy for patients with sickle cell disease (SCD). Oxbryta works by increasing hemoglobin’s affinity for oxygen ...
Finance.yahoo.comFDA expands Oxbryta approval for sickle cell disease
2021-12-17 · Please provide your email address to receive an email when new articles are posted on . The FDA granted accelerated approval to voxelotor tablets for the treatment children aged 4 to 11 years with ...
Healio.comGBT Presents Positive New Data on Oxbryta® (voxelotor) …
2021-12-12 · Oxbryta (voxelotor) tablets prescribing information. South San Francisco, Calif. Global Blood Therapeutics, Inc.; November 2019. Ataga K. et al. N Engl J Med. 2017;376(5):429-439. Contact: Steven ...
Finance.yahoo.comGBT Announces Plans to Seek Regulatory Approval for ...
2020-06-24 · Email Alerts; IR Contact; Press Release View printer-friendly version. Back. GBT Announces Plans to Seek Regulatory Approval for Oxbryta® (voxelotor) to Treat Sickle Cell Patients in Europe. Jun 24, 2020 at 8:30 AM EDT. PDF Version. Intends to seek full marketing authorization for Oxbryta to treat hemolytic anemia in sickle cell disease . Marketing …
Ir.gbt.comFDA approves novel treatment to target abnormality in ...
Oxbryta’s approval was based on the results of a clinical trial with 274 patients with sickle cell disease. In the study, 90 patients received 1500 mg of Oxbryta, 92 patients received 900 mg of ...
Fda.govGlobal Blood's (GBT) Oxbryta Receives Positive CHMP ...
2021-12-17 · E-mail Address. StreetInsider.com Top Tickers, 1/1/2022. 1. SPY 2. XERS 3. TSLA 4. AMD 5. XLNX. 6. FHLD 7. THQ 8. HQH 9. THW 10. NILE. Top News Most Read Special Reports. Wall Street dips as it ...
Streetinsider.comOxbryta®
2020-03-03 · Page 1 VOXELOTOR ORAL CHEMOTHERAPY EDUCATION Name of your medication Generic name voxelotor (vox EL oh tor) Brand name Oxbryta® (ox brye ta) Approved uses Voxelotor is used to treat sickle cell disease. Dose and schedule Taking voxelotor as instructed is important to allow your treatment to be as effective as possible, so here are some …
Oralchemoedsheets.comGBT takes a page from HIV playbook as it embarks on ...
2020-02-13 · GBT takes a page from HIV playbook as it embarks on Oxbryta launch. Global Blood Therapeutics scored its FDA nod for Oxbryta on Nov. 25. (GBT) The sickle cell disease market and patient support ...
Fiercepharma.comGBT's Oxbryta® (voxelotor) Receives Positive CHMP Opinion ...
2021-12-17 · About Oxbryta ® (voxelotor) Tablets Oxbryta (voxelotor) is an oral, once-daily therapy for patients with sickle cell disease (SCD). Oxbryta works by increasing hemoglobin's affinity for oxygen ...
Benzinga.comPrior Authorization Criteria Oxbryta (voxelotor)
Oxbryta (voxelotor) All requests for Oxbryta (voxelotor) require a prior authorization and will be screened for medical necessity and appropriateness using the criteria listed below. Coverage may be provided with a diagnosis of the treatment of Sickle Cell Disease and the following criteria is met: Member is 12 years of age or older. Diagnosis is confirmed by electrophoresis …
Fm.formularynavigator.comPotential SCD Therapies by GBT Safe in Healthy People ...
2021-12-02 · Both Oxbryta and GBT601 work by increasing hemoglobin’s ability to bind to oxygen, thereby preventing its clumping, or polymerization, and the subsequent sickling and destruction of red blood cells — which is SCD’s underlying cause. However, compared with the approved therapy, GBT601 showed greater efficacy at significantly lower doses in a mouse …
Sicklecellanemianews.comGBT Presents Positive New Data on Oxbryta(R) (voxelotor ...
2021-12-12 · About Oxbryta (R) (voxelotor) Tablets Oxbryta (voxelotor) is an oral, once-daily therapy for patients with sickle cell disease (SCD). Oxbryta works by increasing hemoglobin's affinity for oxygen ...
Marketwatch.comTypes of Medications for Sickle Cell Disease | Sickle-Cell.com
2020-11-01 · Oxbryta. The FDA approved Oxbryta in 2019 to treat SCD in people 12 years old and older. It works by preventing sickle hemoglobin from sticking together inside red blood cells. This helps stop red blood cells from sickling. 1,13. Oxbryta improves anemia by increasing hemoglobin levels. It also lowers bilirubin levels and reticulocyte counts ...
Sickle-cell.comGBT erhält positive CHMP-Empfehlung für Oxbryta ...
2021-12-20 · 20.12.2021 – 15:03. GBT. GBT erhält positive CHMP-Empfehlung für Oxbryta® (Voxelotor) zur Behandlung von hämolytischer Anämie bei …
Presseportal.deLG takes ride in Olectra Greentech's electric bus in Jammu ...
2021-12-18 · LG takes ride in Olectra Greentech's electric bus in Jammu. Jammu and Kashmir Lieutenant Governor Manoj Sinha on Saturday took a ride in Olectra Greentech's electric bus from Raj Bhavan till Trikuta Nagar here, which is on a trial run to augment inter-city and intra-city transport facilities in the Union Territory.
Devdiscourse.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| gmahkbsd.org | rumahweb.com | -3 Years, -79 Days |
| ascremecv.com | ovh.com | -3 Years, -176 Days |
| chsafofficial.org | enom.com | -3 Years, -52 Days |
| simply-moroccan.com | namecheap.com | -3 Years, -116 Days |
| cuzideas.com | godaddy.com | -3 Years, -94 Days |
| belkam.info | nic.ru | -3 Years, -276 Days |
| sintermachines.com | godaddy.com | 1 Year, 316 Days |
| simsaopaulo.com | fastdomain.com | -3 Years, -126 Days |
| nakedssl.com | godaddy.com | -2 Years, -293 Days |
| myjalanjournal.com | publicdomainregistry.com | -3 Years, -288 Days |